Literature DB >> 22977397

Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes.

.   

Abstract

Entities:  

Year:  2010        PMID： 22977397      PMCID： PMC3411140     

Source DB:  PubMed          Journal:  CADTH Technol Overv        ISSN： 1203-9012


× No keyword cloud information.
  24 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Effects of a short-acting insulin analog (Insulin Lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus.

Authors:  A Caixàs; A Pérez; A Payés; C Otal; G Carreras; J Ordóñez-Llanos; J Reviriego; J H Anderson; A de Leiva
Journal:  Metabolism       Date:  1998-04       Impact factor: 8.694

3.  Insulin lispro lowers postprandial glucose in prepubertal children with diabetes.

Authors:  L C Deeb; J H Holcombe; R Brunelle; S Zalani; S Brink; M Jenner; H Kitson; K Perlman; M Spencer
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

4.  Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes.

Authors:  Bernhard O Boehm; Julius A Vaz; Lise Brøndsted; Philip D Home
Journal:  Eur J Intern Med       Date:  2004-12       Impact factor: 4.487

5.  Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

Authors:  P D Home; A Lindholm; A Riis
Journal:  Diabet Med       Date:  2000-11       Impact factor: 4.359

6.  Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group.

Authors:  F Holleman; H Schmitt; R Rottiers; A Rees; S Symanowski; J H Anderson
Journal:  Diabetes Care       Date:  1997-12       Impact factor: 19.112

7.  Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.

Authors:  John H Holcombe; Sunita Zalani; Vipin K Arora; Casey J Mast
Journal:  Clin Ther       Date:  2002-04       Impact factor: 3.393

8.  Special management of insulin lispro in continuous subcutaneous insulin infusion in young diabetic children: a randomized cross-over study.

Authors:  Nadia Tubiana-Rufi; Regis Coutant; Juliette Bloch; Geraldine Munz-Licha; Christine Delcroix; Nathalie Montaud-Raguideau; Rolande Ducrocq; Jean-Marie Limal; Paul Czernichow
Journal:  Horm Res       Date:  2004-10-22

9.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

10.  Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.

Authors:  Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391
View more
  6 in total

Review 1.  The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women.

Authors:  Robert B Hopkins; Ron Goeree; Eleanor Pullenayegum; Jonathan D Adachi; Alexandra Papaioannou; Feng Xie; Lehana Thabane
Journal:  BMC Musculoskelet Disord       Date:  2011-09-26       Impact factor: 2.362

2.  Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.

Authors:  Sumeet R Singh; Fida Ahmad; Avtar Lal; Changhua Yu; Zemin Bai; Heather Bennett
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

3.  Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin.

Authors:  Sarah E Holden; Chris D Poole; Christopher Ll Morgan; Craig J Currie
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

4.  Soluble insulin analogs combining rapid- and long-acting hypoglycemic properties - From an efficient E. coli expression system to a pharmaceutical formulation.

Authors:  Diana Mikiewicz; Anna Bierczyńska-Krzysik; Agnieszka Sobolewska; Dorota Stadnik; Monika Bogiel; Monika Pawłowska; Anna Wójtowicz-Krawiec; Piotr A Baran; Natalia Łukasiewicz; Agnieszka Romanik-Chruścielewska; Iwona Sokołowska; Jacek Stadnik; Piotr Borowicz; Grażyna Płucienniczak; Andrzej Płucienniczak
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

5.  Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews.

Authors:  Krzysztof Studziński; Tomasz Tomasik; Janusz Krzyszton; Jacek Jóźwiak; Adam Windak
Journal:  BMJ Open       Date:  2017-03-08       Impact factor: 2.692

6.  Evidence summaries: the evolution of a rapid review approach.

Authors:  Sara Khangura; Kristin Konnyu; Rob Cushman; Jeremy Grimshaw; David Moher
Journal:  Syst Rev       Date:  2012-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.